Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Anesthesiology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Chapter 129: laboratory evaluation of hemostatic and thrombotic disorders.in: Hoffman R. Benz E. Silberstein L. Hematology, basic principles and practice. 7th ed. Elsevier, Philadelphia2018: 1922-1931
- Coagulation testing in the core laboratory.Lab Med. 2017; 48: 295-313
- Chapter 19: coagulation monitoring.in: Kaplan J. Kaplan's cardiac anesthesia. 7th ed. Elsevier, Philadelphia2017: 698-727
- Viscoelastic testing inside and beyond the operating room.J Thorac Dis. 2017; 9: S299-S308
- Antithrombotic drugs.in: Hoffman R. Benz E.J. Silberstein L.E. Hematology: basic principles and practice. 7th edition. Elsevier, Philadelphia2018: 2168-2188
- A review of guidelines on anticoagulation reversal across different clinical scenarios––Is there a general consensus?.Am J Emerg Med. 2020; 38: 1890-1903
- Four-factor prothrombin complex concentrate versus plasma for rapid vitamin K antagonist reversal in patients needing urgent surgical or invasive interventions: a phase 3b, open-label, non-inferiority, randomized trial.Lancet. 2015; 385: 2077-2087
- Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal: a systematic review and meta-analysis.Thromb Haemost. 2016; 116: 879-890
- Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine.Neurocrit Care. 2015; 24: 6-46
- Fixed versus variable dosing of prothrombin complex concentrate for bleeding complications of vitamin K antagonists––the PROPER3 randomized clinical trial.Ann Emerg Med. 2022; 79: 20-30
- Chapter 45: anticoagulant and antiplatelet therapy.in: Hemminds H.C. Egan T.D. Pharmacology and physiology for anesthesia: foundations and clinical application. 2nd edition. Elsevier, Philadelphia2019: 870-894
- Chapter 95: Hemostasis, thrombosis, fibrinolysis, and cardiovascular disease.in: Libby P. Bonow R.O. Mann D.L. Braunwald’s heart disease: a textbook of cardiovascular medicine. 12th edition. Elsevier, Philadelphia2022: 1766-1790
- Andexanet alfa for the reversal of factor Xa inhibitor activity.N Engl J Med. 2015; 373: 2413-2424
- Controversies in heparin monitoring.Am J Hematol. 2012; 87: S137-S140
- Anticoagulation reversal.Emerg Med Clin North America. 2018; 36: 585-601
- Full study report of andexanet alfa for bleeding associated with factor Xa inhibitors.N Engl J Med. 2019; 380: 1326-1335
- Use of direct oral anticoagulants in ICU patients. Part I––applied pharmacology.Anaesthesiol Intensive Ther. 2021; 53: 429-439
- Direct Oral Anticoagulant Use: A Practical Guide to Common Clinical Challenges.J Am Heart Assoc. 2020; 9: e017559
- 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the american college of cardiology task force on expert consensus decision pathways.J Am Coll Cardiol. 2017; 70: 3042-3067
- Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report.Chest. 2021; 160: e545-e608
- Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.BMJ. 2017; 359: j5058
- Use of direct oral anticoagulants in ICU patients. Part II- Clinical evidence.Anaesthesiol Intensive Ther. 2021; 53: 440-449
- Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study.J Am Coll Cardiol. 2013; 61: 2264-2273
- How I treat target-specific oral anticoagulant-associated bleeding.Blood. 2014; 123: 1152-1158
- Worldwide management of oral anticoagulant therapy: the ISAM study.J Thromb Thrombolysis. 2006; 21: 73-77
- Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270.Blood. 2003; 101: 3908-3914
- How I use laboratory monitoring of antiplatelet therapy.Blood. 2017; 130: 713-721
- Platelet function testing in patients on antiplatelet therapy before cardiac surgery.Anesthesiology. 2020; 133: 1263-1276
- Emergency reversal of anticoagulation.West J Emerg Med. 2019; 20: 770-783
- Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion model.Thromb Res. 2015; 136: 1216-1223
- Population pharmacokinetic-pharmacodynamic modeling of PB2452, a monoclonal antibody fragment being developed as a ticagrelor reversal agent, in healthy volunteers.CPT Pharmacometrics Syst Pharmacol. 2022; 11: 68-81
- Multi-modal characterization of the coagulopathy associated with extracorporeal membrane oxygenation.Crit Care Med. 2020 May; 48: e400-e408
- Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).Intensive Care Med. 2012; 38: 62-68
- Vitamin K deficiency in cancer patients referred to a hospital palliative care team with bleeding and the impact of vitamin K replacement on laboratory indicators of vitamin K status.Int J Lab Hematol. 2013; 35: 457-459
- Treatment of bleeding in dialysis patients.Semin Dial. 2009; 22: 279-286
- Trauma-induced coagulopathy: The past, present, and future.J Thromb Haemost. 2019; 17: 852-862
- Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hemorrhage (CRASH-2): a randomized, placebo-controlled trial.Lancet. 2010; 376: 23-32
Article info
Footnotes
The authors declare no relevant material or financial interests that relate to the research described in this article.
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
